menu
    • menu
    PHARMACOMPASS
    PHARMACOMPASS

    Grow Your Pharma Business Digitally
    X
    Market Place Market Place
    Sourcing support Sourcing Support
    API / FDF
    Excipients
    Services
    Developments
    News
    Market Intel
    #Phispers
    #SpeakPharma
    #LearnMore

    NEWS

    DRUGS & DEVELOPMENTS

    MARKET INTEL by PharmaCompass

    Polfa Tarchomin is a leading Polish pharmaceutical company with 200 year tradition in manufacture and sale of pharmaceutical products.

    Pfizer wins $107.5M from AZ in US cancer drug patent trial

    REUTERS

    Wyeth Pharma`s Biologic Besponsa (inotuzumab ozogamicin) Receives Approval in the U.S.

    FDA

    Wyeth’s Mylotarg (Gemtuzumab Ozogamicin) Receives Supplemental Approval In US

    FDA

    FDA approves gemtuzumab ozogamicin for CD33-positive AML in pediatric patients

    FDA

    Wyeth’s Mylotarg (Gemtuzumab Ozogamicin) Receives Supplemental Approval In US

    FDA

    Wyeth Pharm’s Mylotarg (Gemtuzumab Ozogamicin) Receives Supplemental Approval In US

    FDA

    Wyeth Pharm’s Inotuzumab Ozogamicin Receives Supplemental Approval In US

    FDA

    Pfizer faces first 2017 patent loss as Pristiq generics crash the party

    FIERCE PHARMA

    Pfizer Resubmits US and EU Application for Withdrawn ADC Mylotarg

    BIOPHARMA REPORTER

    Is Biopharma Productivity In A Sharp Decline?

    FORBES

    West Chester agrees to settle litigation with Wyeth, Pfizer

    DAILY LOCAL

    Novartis drug Afinitor® significantly reduces seizures in Phase III study of patients with tuberous sclerosis complex

    PR NEWS WIRE

    Aurobindo Pharma gets final USFDA nod for gastro reflux drug

    ECONOMIC TIMES

    Another FDA delay at Puma triggers fresh doubts, sharp drop in share price

    FIERCE BIOTECH

    Pfizer whistleblowers set to collect $59M in Medicaid fraud suit

    FIERCE PHARMA

    Pfizer unit to pay $784.6 mln in Medicaid rebate settlement

    REUTERS

    Reasons Pfizer is a Bargain Now and Why It Doesn’t Want to be Known as Pfizer

    BIOSPACE

    More U.S. women using unapproved menopause hormones

    REUTERS

    Pfizer-Allergan Merger Raises Concerns That Fraud Is Part Of `Corporate DNA`

    FORBES

    Pfizer-Allergan Merger Won`t Lead to New, Innovative Drugs

    US NEWS

    Veteran job-choppers Pfizer Allergan joining hands,how many layoffs in cards?

    FIERCE PHARMA

    Pfizer -Allergan Combo: Facility Numbers, the Biggest Headcount

    BIOSPACE

    Top 100 pharma cos report 1.8% growth in profit, sales grew by 7% during 2014-15

    PHARMABIZ

    Canadian HRT users can claim compensation from $13M fund

    THE STAR

    NCE Exclusivity Challenges are hot! Hot! HOT! Ferring Lets Loose with the Latest Lawsuit Challenging Denial of NCE Exclusivity for Colon Cleansing Drug

    FDA LAW BLOG

    Wyeth`s Rapamune (sirolimus) Approved in USA For LAM

    FDA

    Pfizer Dumps a Hemophilia Pact with Catalyst, Threatening a Merger with Targacept

    FIERCE BIOTECH

    Anvisa suspends distribution of Pfizer contraceptive

    ANVISA

    Copyright © 2025 LePro PharmaCompass OPC Private Limited, All rights reserved.